Assignee
KANDY THERAPEUTICS LTD
GB·6 granted patents·4 pending applications·20 citations·filing 2018–2025
Top patents by PatentIndex Score
10 records- 0192US11767328B2Method of treatment of symptoms of menopauseKANDY THERAPEUTICS LTD·Filed 2023·Granted Sep 26, 2023·3 cites·31 claims
- 0292US11591346B2Method of treatment of symptoms of menopauseKANDY THERAPEUTICS LTD·Filed 2020·Granted Feb 28, 2023·6 cites·34 claims
- 0391US12264164B2Method of treatment of symptoms of menopauseKANDY THERAPEUTICS LTD·Filed 2023·Granted Apr 1, 2025·2 cites·23 claims
- 0491US11787820B2Method of treating certain sex hormone-dependent diseases administering a soft gelatin capsule comprising NK1 and NK3 receptors antagonistsKANDY THERAPEUTICS LTD·Filed 2020·Granted Oct 17, 2023·3 cites·41 claims
- 0587US10774091B2Soft gelatin capsule formulationKANDY THERAPEUTICS LTD·Filed 2019·Granted Sep 15, 2020·6 cites·24 claims
- 0681US2026014166A1Novel uses of dual nk-1 /nk-3 receptor antagonists for treating sex-hormone diseasesKANDY THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0770US2025154167A1Method of treatment of symptoms of menopauseKANDY THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 0868US2021128574A1Novel usesKANDY THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 0968US2021236506A1Novel usesKANDY THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1051US12473260B2Chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of NT-814KANDY THERAPEUTICS LTD·Filed 2020·Granted Nov 18, 2025·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when KANDY THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →